PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2020.28920215341184-1194Effectiveness and Safety of Clofarabine Monotherapy or Combination Treatment in Relapsed/Refractory Childhood Acute Lymphoblastic Leukemia: A Pragmatic, Non-interventional Study in KoreaJung Yoon Choi, Che Ry Hong, Kyung Taek Hong, Hyoung Jin Kang, Seongkoo Kim, Jae Wook Lee, Pil Sang Jang, Nack-Gyun Chung, Bin Cho, Hyery Kim, Kyung-Nam Koh, Ho Joon Im, Jong Jin Seo, Seung Min Hahn, Jung Woo Han, Chuhl Joo Lyu, Eu Jeen Yang, Young Tak Lim, Keon Hee Yoo, Hong Hoe Koo, Hoon Kook, In Sang Jeon, Hana Cho, Hee Young Shinhttp://e-crt.org/upload/pdf/crt-2020-289.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2020.289, http://e-crt.org/upload/pdf/crt-2020-289.pdf
Childhood Acute Lymphoblastic Leukemia10.1007/978-3-319-39708-5_112017255-297Relapsed Acute Lymphoblastic Leukemia of ChildhoodSu Han Lum, Denise Bonney, Vaskar Sahahttp://link.springer.com/content/pdf/10.1007/978-3-319-39708-5_11
Acta Haematologica Polonica10.2478/ahp-2020-00312020513179-182Clofarabine combined with etoposide and cyclophosphamide for refractory and multiple relapsed childhood B-cell precursor acute lymphoblastic leukemia: an experience of the Polish Pediatric Leukemia/Lymphoma Study GroupJacek Wachowiak, Jan Styczyński, Joanna Owoc-Lempach, Ewa Gorczyńska, Agnieszka Zaucha-Prażmo, Jerzy Kowalczyk, Tomasz Szczepański, Walentyna Balwierzhttps://content.sciendo.com/view/journals/ahp/51/3/article-p179.xml, https://content.sciendo.com/downloadpdf/journals/ahp/51/3/article-p179.xml
Mediterranean Journal of Hematology and Infectious Diseases10.4084/mjhid.2019.0322019111e2019032A real-world study on Clofarabine and Cytarabine combination in patients with relapsed/refractory acute myeloid leukemiaClaudio Fozzahttps://www.mjhid.org/index.php/mjhid/article/download/2019.032/3624, https://www.mjhid.org/index.php/mjhid/article/download/2019.032/3624
Pediatrics International10.1111/ped.1283720155761059-1066Childhood relapsed acute lymphoblastic leukemia: Biology and recent treatment progressHiroaki Gotohttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fped.12837, http://onlinelibrary.wiley.com/wol1/doi/10.1111/ped.12837/fullpdf
Clinical Lymphoma Myeloma and Leukemia10.1016/j.clml.2014.06.031201414S115A Pilot Study of Mitoxantrone in Combination With Clofarabine (MITCL) in Children, Adolescents and Young Adults (CAYA) With Refractory/Relapsed Acute Leukemia or High Grade Non-Hodgkin LymphomaJessica Hochberg, Javier Oesterheld, Olga Militano, Sumith Roy, Lauren Harrison, Mitchell S. Cairohttps://api.elsevier.com/content/article/PII:S2152265014001864?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2152265014001864?httpAccept=text/plain
Chemotherapy10.1159/0001186642008542120-124The Combination of Clofarabine and Cytarabine in Pediatric Relapsed Acute Lymphoblastic Leukemia: A Case ReportPooja Gidwani, K.H. Ramesh, Yingxian Liu, Edward Anders Kolbhttps://www.karger.com/Article/Pdf/118664, https://www.karger.com/Article/Pdf/118664
Childhood Leukemias10.1017/cbo9780511977633.0152012367-382Relapsed acute lymphoblastic leukemiaGünter Henze, Arend von Stackelberghttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/49B2A32E7C71D6940ABAEE128C5D0C4A
Leukemia Research10.1016/j.leukres.2017.09.01620176229-33Efficacy and safety of G-CSF, low-dose cytarabine and aclarubicin in combination with l -asparaginase, prednisone in the treatment of refractory or relapsed acute lymphoblastic leukemiaKeshu Zhou, Yongping Song, Yanli Zhang, Xudong Wei, Yuewen Fu, Fengkuan Yu, Hu Zhou, Xinjian Liu, Jian Zhou, Baijun Fanghttps://api.elsevier.com/content/article/PII:S0145212617305246?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0145212617305246?httpAccept=text/plain
Childhood Leukemias10.1017/cbo9780511471001.0182006473-486Relapsed acute lymphoblastic leukemiaGünter Henze, Arend von Stackelberghttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/5E950644B13CC5C8009DD0AB9FAC67B1